Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology: Clinical Diagnosis: Leukemia/Lymphoma/Myeloma

  • You have access
    Value of FDG-PET in ocular adnexal lymphoma (OAL) compared with MR imaging
    Kazumasa Hayasaka, Takashi Yamashita, Tomoya Saitoh, Masamichi Koyama and Takashi Nihashi
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1870;
  • You have access
    Quantitative response assessment by interim FDG-PET in aggressive non-Hodgkin lymphoma (NHL) using SUV change and lymphoma-to-reference tissue ratios
    Stefan Müller, Hong Ngo, Ulrich Dührsen, Andreas Bockisch and Andreas Hüttmann
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1867;
  • You have access
    Whole-body MRI, including diffusion-weighted imaging, compared to FDG-PET/CT for staging newly diagnosed lymphoma: Initial results
    Thomas Kwee, John De Klerk, Rob Fijnheer, Henriëtte Quarles van Ufford, Frederik Beek, Taro Takahara, Willem Mali and Rutger Nievelstein
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1869;
  • You have access
    18FDG-PET/CT in detection of primary tumors in metastatic carcinoma of unknown primary site
    Ramya Soundar, Rakesh Kumar, Niraj Naswa, Bangkim Khangembam, Varun Dhull, Manas Sahoo, Chandrasekhar Bal, Guru Bandopadhyaya and Arun Malhotra
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1868;
  • You have access
    FDG-PET/CT for the detection of gastrointestinal graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Marie Lacombe, Mohamad Mohty, Thomas Eugene, Catherine Ansquer, Francoise Kraeber-Bodere, Thomas Carlier, Thierry Guillaume, Patrice Chevallier, Jacques Delaunay and Caroline Bodet-Milin
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1877;
  • You have access
    Clinical usefulness of F-18 FDG PET/CT in patients with hemophagocytic lymphohistiocytosis
    Jahae Kim, Ho-Chun Song, Sae-Ryung Kang, Su Woong Yoo, Jong-Ryool Oh, Ari Chong, Jung-Joon Min, Hee-Seung Bom and Jae-Sook Ahn
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1875;
  • You have access
    Usefulness of FDG PET/CT in patients with gastrointestinal lymphoma
    Khushboo Gupta, Dr. B.A. Krishna, Natasha Singh and Joppy Antony
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1879;
  • You have access
    Comparison of London criteria and quantitative analysis in interpretation of interim F-18-FDG PET-CT in high grade non Hodgkin's lymphoma
    Manohar Kuruva, Bhagwant Mittal, Karri Kashyap, Baljinder Singh, Anish Bhattacharya and Pankaj Malhotra
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1871;
  • You have access
    Value of FDG-PET/CT and LDH level in detecting extramedullary disease in multiple myeloma
    Andrea Itskovich, Lorraine De Blanche, Tracy Brown, Bart Barlogie, Saad Usmani, Nathan Petty, Terri Alpe and Twyla Bartel
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1866;
  • You have access
    Paediatric non Hodgkin’s lymphoma: Prognostic value of early interim FDG PET/CT done after two cycles of chemotherapy
    Punit Sharma, Rakesh Kumar, Sameer Bakhshi and Arun Malhotra
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1872;

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire